WEBVTT

1
00:00:00.088 --> 00:00:02.250
This podcast is created by Coelis,

2
00:00:02.550 --> 00:00:06.693
a pilot study on the target microwave ablation for BPH.

3
00:00:06.933 --> 00:00:13.998
The pilot trial completed 12 patients and all of them actually had significant improvement in terms of urinary symptoms.

4
00:00:21.022 --> 00:00:21.723
Dear listeners,

5
00:00:22.023 --> 00:00:25.425
welcome to another captivating episode of Prostatalk,

6
00:00:25.886 --> 00:00:29.208
where we usually dive deep into the world of prostate cancer.

7
00:00:29.876 --> 00:00:39.540
I'm your host Thomas and today we are taking a little detour down the prostate cancer pathway to explore the realm of benign prostatic hyperplasia,

8
00:00:39.900 --> 00:00:40.480
BPH.

9
00:00:40.941 --> 00:00:41.541
Don't worry,

10
00:00:41.921 --> 00:00:44.782
we promise to keep it benignly entertaining.

11
00:00:45.082 --> 00:00:48.004
Admit the serious discussion about prostate cancer,

12
00:00:48.444 --> 00:00:52.646
BPH often feels like the overlooked cousin at the family reunion.

13
00:00:53.126 --> 00:00:53.826
But fear not,

14
00:00:54.266 --> 00:00:54.386
Dr.

15
00:00:54.526 --> 00:00:58.428
Chu is here to turn the spotlight on BPH and provide insights.

16
00:00:58.728 --> 00:00:59.729
Welcome on board Dr.

17
00:00:59.789 --> 00:01:01.270
Peter Chu to Prostatalk,

18
00:01:01.570 --> 00:01:05.293
where even the benign conditions get their moment in the spotlight.

19
00:01:08.815 --> 00:01:09.375
Hello Dr.

20
00:01:09.556 --> 00:01:09.676
Chu,

21
00:01:09.976 --> 00:01:12.297
welcome again to this new episode of Prostatalk.

22
00:01:12.618 --> 00:01:14.859
How are you since last time we have seen each other?

23
00:01:15.520 --> 00:01:15.980
Hi Thomas,

24
00:01:16.680 --> 00:01:22.464
I'm doing very good and the trials in both prostate cancer and the BPH are still ongoing.

25
00:01:22.725 --> 00:01:26.047
I'm very excited to continue to work on these studies.

26
00:01:26.907 --> 00:01:27.368
Perfect.

27
00:01:27.748 --> 00:01:28.248
First of all,

28
00:01:28.308 --> 00:01:32.810
could you please introduce yourself quickly for our listeners who don't know you yet?

29
00:01:33.690 --> 00:01:36.212
I'm an academic urologist in Hong Kong,

30
00:01:36.492 --> 00:01:37.932
in the Chinese University of Hong Kong.

31
00:01:38.452 --> 00:01:40.213
My main interest is in prostate,

32
00:01:40.233 --> 00:01:42.914
so both prostate cancer and benign prostatic hyperplasia.

33
00:01:43.675 --> 00:01:49.657
I'm working on novel minimal invasive treatment options for both of these conditions.

34
00:01:50.117 --> 00:01:51.258
Thanks for this introduction.

35
00:01:51.718 --> 00:01:54.519
We used to talk about prostate cancer in this podcast,

36
00:01:54.579 --> 00:01:56.660
but today we talk about benign...

37
00:01:56.840 --> 00:01:58.481
prostatic hyperplasia.

38
00:01:58.882 --> 00:02:01.624
Could you tell us some words about this disease?

39
00:02:01.944 --> 00:02:03.686
Benign prostatic hyperplasia,

40
00:02:03.866 --> 00:02:04.506
BPH,

41
00:02:04.746 --> 00:02:05.567
is a very,

42
00:02:05.627 --> 00:02:08.229
very common condition in men,

43
00:02:08.870 --> 00:02:10.311
not always in elderly,

44
00:02:10.671 --> 00:02:12.673
actually sometimes in middle age,

45
00:02:13.113 --> 00:02:13.514
50-something.

46
00:02:14.334 --> 00:02:20.199
It's actually much more common in prostate cancer and affecting so many thousands and tens of thousands of men.

47
00:02:20.359 --> 00:02:26.004
The demand for optimal treatment and treatment for BPH with less morbidity.

48
00:02:26.568 --> 00:02:27.369
is in high demand.

49
00:02:27.949 --> 00:02:30.911
You mentioned that it's most common that prostate cancer.

50
00:02:31.251 --> 00:02:38.475
How common is these conditions and what are some key characteristics of patients who are affected by BPH?

51
00:02:39.275 --> 00:02:40.536
As men age,

52
00:02:41.177 --> 00:02:42.758
say beyond 60 or 70,

53
00:02:43.738 --> 00:02:52.483
like two or three or even more men will be affected with some urinary symptoms that is mostly related to the benign prostate hyperplasia.

54
00:02:53.043 --> 00:02:53.404
As said,

55
00:02:53.484 --> 00:02:53.684
this

56
00:02:53.944 --> 00:03:22.840
problem is very very common in the past most of these men would take drugs some medications to improve the symptoms which work for some time but eventually the drugs will not work so well in some men and they will need to consider surgical treatment and in the past surgical treatment like transurethral resection of the prostate terp carries some morbidity and a lot of men are actually very resistant in receiving the terp because

57
00:03:23.100 --> 00:03:26.602
part of the sexual function will be gone after receiving this treatment.

58
00:03:26.883 --> 00:03:30.885
Men would tolerate a lot of these symptoms and keep on the medications.

59
00:03:31.186 --> 00:03:31.626
And by the way,

60
00:03:31.626 --> 00:03:34.508
the medications also harm the sexual function too.

61
00:03:34.788 --> 00:03:37.570
These men are in a pretty frustrated status,

62
00:03:37.670 --> 00:03:37.950
actually.

63
00:03:38.431 --> 00:03:45.015
I know that there are sometimes patients or people directly concerned by prostate disease who listen to us.

64
00:03:45.495 --> 00:03:46.456
So my question is,

65
00:03:46.776 --> 00:03:51.339
what are the typical symptoms of BPH that patients should be aware of?

66
00:03:51.680 --> 00:03:51.980
Are there...

67
00:03:52.220 --> 00:03:56.223
any warning sign that indicate the need of immediate medical attention?

68
00:03:56.944 --> 00:03:57.164
Right.

69
00:03:57.204 --> 00:04:01.627
So most of these men with BPH have a range of symptoms.

70
00:04:01.727 --> 00:04:03.488
They don't necessarily have all of them,

71
00:04:03.669 --> 00:04:05.330
but they might have one or two or more.

72
00:04:05.930 --> 00:04:09.693
So that includes usually slow stream very commonly,

73
00:04:09.913 --> 00:04:13.336
and they're taking much longer time to finish their pee.

74
00:04:13.736 --> 00:04:14.737
And after they pee,

75
00:04:14.897 --> 00:04:18.800
they don't feel like they've completely emptied the bladder.

76
00:04:18.960 --> 00:04:19.620
On the other hand,

77
00:04:20.101 --> 00:04:22.602
there are also symptoms of urgency,

78
00:04:23.023 --> 00:04:23.563
frequency,

79
00:04:24.023 --> 00:04:24.724
and nocturia,

80
00:04:25.084 --> 00:04:28.667
which are all quite bothersome to men.

81
00:04:29.067 --> 00:04:36.012
These symptoms on its own or in combination would affect the quality of life of these men.

82
00:04:36.372 --> 00:04:36.832
Definitely.

83
00:04:37.433 --> 00:04:38.333
And many of them,

84
00:04:39.734 --> 00:04:40.795
if they're very mild,

85
00:04:41.215 --> 00:04:44.197
then they might still observe or what we call tolerate the symptoms.

86
00:04:44.517 --> 00:04:45.698
But further on,

87
00:04:45.718 --> 00:04:46.639
they need to take drugs.

88
00:04:46.859 --> 00:04:47.659
And afterwards,

89
00:04:47.739 --> 00:04:48.360
as I've said.

90
00:04:48.716 --> 00:04:50.217
they may need to consider surgery.

91
00:04:50.697 --> 00:04:54.859
What are the current treatment options available for patients with BPH?

92
00:04:55.020 --> 00:05:01.083
Could you briefly describe each option and discuss their efficacy and potential side effects?

93
00:05:01.587 --> 00:05:05.749
In terms of surgical treatment for BPH,

94
00:05:06.469 --> 00:05:09.531
there are actually a long list of treatment options.

95
00:05:09.651 --> 00:05:09.891
Okay.

96
00:05:10.271 --> 00:05:10.491
Well,

97
00:05:10.891 --> 00:05:16.374
this depends on the size of the prostate and any complications related to the BPH.

98
00:05:17.254 --> 00:05:17.894
In general,

99
00:05:18.114 --> 00:05:25.738
for patients that has not had any retention of urine or severe complication like obstructive uropathy and impaired renal function,

100
00:05:25.998 --> 00:05:27.839
so mainly for lower urinary tract symptoms,

101
00:05:28.339 --> 00:05:28.459
the...

102
00:05:28.559 --> 00:05:36.365
The gold standard or the most so-called gold standard or most commonly performed surgical treatment is the transurethral resection of prostate or TURP.

103
00:05:36.626 --> 00:05:37.466
In recent years,

104
00:05:38.067 --> 00:05:40.148
for prostates of medium-sized,

105
00:05:40.509 --> 00:05:42.330
like between 30 to 80 gram,

106
00:05:42.711 --> 00:05:56.322
there are actually a lot of new treatment options like intraprosthetic injection of steam or putting in urethral implants like the prosthetic urethral lift or even putting in temporary stents like the ITIN.

107
00:05:56.462 --> 00:05:57.783
So there are actually a lot of...

108
00:05:57.923 --> 00:06:05.606
options out there but what I'm working on now the microwave ablation is another very exciting new treatment coming up.

109
00:06:06.306 --> 00:06:13.069
When determining the most appropriate treatment for a patient with BPH what factors do you take into consideration?

110
00:06:13.609 --> 00:06:19.032
Are there certain patient characteristics or preferences that influence your decision making process?

111
00:06:20.252 --> 00:06:27.295
So the consideration of surgical treatment would depend on firstly the prostate size so

112
00:06:27.795 --> 00:06:29.676
for very large prostates,

113
00:06:29.836 --> 00:06:31.617
like more than 80 or 100 grams,

114
00:06:31.877 --> 00:06:35.818
TURP or even inuclation of the prostate will be more appropriate.

115
00:06:35.878 --> 00:06:39.200
But most men actually do not have the prostate that is so big.

116
00:06:39.540 --> 00:06:45.982
So most men with the BPH symptoms that requires treatment would have prostate size of less than 80 grams.

117
00:06:46.303 --> 00:06:48.744
So this size is a consideration.

118
00:06:49.304 --> 00:06:49.744
Secondly,

119
00:06:51.205 --> 00:06:54.426
is there any complication like recurring infection,

120
00:06:54.606 --> 00:06:55.446
bladder stone,

121
00:06:55.706 --> 00:06:56.727
retention of urine?

122
00:06:56.847 --> 00:06:56.967
And

123
00:06:57.343 --> 00:07:01.726
and impaired renal function related to obstructive uropathy due to BPH obstruction.

124
00:07:01.906 --> 00:07:06.909
So these are all considerations of which treatment type that we will choose for the patient.

125
00:07:07.289 --> 00:07:16.074
Are there any recent advancement of emerging treatments in the field of BPH that you find particularly promising or not worthy?

126
00:07:16.654 --> 00:07:22.097
I've mentioned just now there are a few minimally invasive surgical treatment for BPH missed.

127
00:07:22.417 --> 00:07:22.838
As said,

128
00:07:23.158 --> 00:07:24.999
I've talked about a steam injection.

129
00:07:25.499 --> 00:07:29.122
and the prosthetic urethral lift or temporary prosthetic stents.

130
00:07:29.282 --> 00:07:32.485
These are all useful techniques to help.

131
00:07:32.745 --> 00:07:34.747
They all have their goods and bads.

132
00:07:35.147 --> 00:07:35.727
And therefore,

133
00:07:36.608 --> 00:07:43.634
we are now actually exploring further options down the road to see if there are any better options for the patients.

134
00:07:44.094 --> 00:07:45.055
And for the record,

135
00:07:45.115 --> 00:07:45.596
last time,

136
00:07:45.656 --> 00:07:49.359
we talked about targeted micro-revablation for prostate cancer.

137
00:07:49.859 --> 00:07:50.299
And today,

138
00:07:50.379 --> 00:07:54.543
I would like to talk with you about the use of this energy for benign...

139
00:07:54.823 --> 00:07:56.443
prostatic hyperplasia.

140
00:07:56.884 --> 00:08:01.465
Could you please remind us what is targeted microwave technology?

141
00:08:01.965 --> 00:08:10.487
This is a needle ablation done through transparent insertion of that very small microwave needle of 17 gauge.

142
00:08:11.127 --> 00:08:23.651
And the role of it is to perform ablation of prostate tissue such that the ablated area will shrink and subsequently prostate volume will reduce and the pressure.

143
00:08:23.987 --> 00:08:30.752
on the prostate urethra will decrease in order to achieve a reduction of bladder outlet obstruction.

144
00:08:31.072 --> 00:08:32.233
And in the end,

145
00:08:32.313 --> 00:08:35.795
we would like to achieve a reduction of obstruction,

146
00:08:35.895 --> 00:08:40.799
improvement of urinary flow and reduction of urinary symptoms in these patients.

147
00:08:41.339 --> 00:08:45.002
And some studies have already been published for prostate cancer.

148
00:08:45.562 --> 00:08:46.243
And if

149
00:08:46.623 --> 00:08:47.323
I'm not wrong,

150
00:08:47.604 --> 00:08:49.065
I could see a few papers from you,

151
00:08:49.285 --> 00:08:49.705
at last,

152
00:08:49.725 --> 00:08:51.286
EAU and AUA 2024.

153
00:08:52.627 --> 00:08:58.650
So you have just finished a trial for targeted microwave ablation for benign prostatic hyperplasia.

154
00:08:58.910 --> 00:08:59.490
Is that right?

155
00:09:00.090 --> 00:09:04.592
We have done a pilot study on the targeted microwave ablation for BPH.

156
00:09:05.092 --> 00:09:16.777
The pilot trial completed 12 patients and all of them actually had significant improvement in terms of urinary symptoms and the flow of the urine as tested objectively.

157
00:09:17.077 --> 00:09:21.539
We are now going to expand this treatment option into another phase.

158
00:09:21.779 --> 00:09:24.760
in a clinical trial so we can treat more patients.

159
00:09:25.020 --> 00:09:33.824
And we actually have a plan of subsequent trials coming up to help us to know better the goods and bads of this treatment.

160
00:09:34.144 --> 00:09:34.344
Okay.

161
00:09:35.225 --> 00:09:40.127
And so what brings you to test targeted microevaporation technology for this pathology?

162
00:09:40.647 --> 00:09:44.409
So we have been doing a lot of steam injection in Hong Kong for BPH.

163
00:09:44.729 --> 00:09:47.430
It's actually giving us some good results too,

164
00:09:47.650 --> 00:09:49.271
but at the same time it...

165
00:09:49.531 --> 00:09:49.771
I mean,

166
00:09:49.791 --> 00:09:54.292
steam is injected transurethrally through the prostate urethra into the prostate.

167
00:09:54.533 --> 00:10:02.995
So sometimes it would cause quite a lot of early periurethral edema on the prostate and sometimes hematuria in the first few days.

168
00:10:03.295 --> 00:10:10.177
And so we are exploring newer options that we can avoid puncturing the prostate urethra,

169
00:10:10.397 --> 00:10:15.579
and that is through the transperineal skin directly into the prostate in order to do the ablation.

170
00:10:15.960 --> 00:10:19.049
This is quite early on in the clinical trial,

171
00:10:19.631 --> 00:10:21.337
but we are quite optimistic.

172
00:10:21.809 --> 00:10:24.331
that this is going to be a very exciting new treatment.

173
00:10:24.671 --> 00:10:25.632
Definitely exciting.

174
00:10:26.152 --> 00:10:30.595
Is everybody concerned by this treatment or do you have any criterias?

175
00:10:31.636 --> 00:10:32.757
In the clinical trial,

176
00:10:33.077 --> 00:10:38.261
we choose patients who are at least moderate to severe urinary symptoms,

177
00:10:38.461 --> 00:10:41.563
prostate size of between 30 to 80 gram,

178
00:10:41.803 --> 00:10:50.109
which is actually the inclusion criteria of most other minimally invasive surgical treatments out there.

179
00:10:50.409 --> 00:11:00.675
We plan to compare these results with the results of the other modalities and see whether there is any advantage of this microwave ablation over the other treatments.

180
00:11:01.235 --> 00:11:02.155
And may I ask,

181
00:11:02.536 --> 00:11:04.457
what are the results as far today?

182
00:11:05.197 --> 00:11:08.859
As demonstrated in a few abstract papers,

183
00:11:09.239 --> 00:11:13.241
the initial results of the microwave ablation were very encouraging.

184
00:11:13.341 --> 00:11:19.565
There was significant improvement of the urinary symptoms in terms of the reduction of symptom score.

185
00:11:19.565 --> 00:11:20.065
Thank you.

186
00:11:20.437 --> 00:11:20.697
from

187
00:11:21.578 --> 00:11:23.560
28 down to about 8.

188
00:11:23.760 --> 00:11:27.403
So this was a huge improvement of 20

189
00:11:27.883 --> 00:11:28.784
IPSS points,

190
00:11:29.204 --> 00:11:32.647
which is not commonly seen in other MIST trials.

191
00:11:33.628 --> 00:11:42.575
We are looking forward to the next trial which would have more patients and this is going to be conducted in Europe.

192
00:11:43.276 --> 00:11:49.261
And we are also lining up the third trial in comparing with other BPH treatments.

193
00:11:49.881 --> 00:11:51.042
It's quite encouraging,

194
00:11:51.162 --> 00:11:51.683
definitely.

195
00:11:52.143 --> 00:11:56.326
And do you have already any feedback from the patient's comfort?

196
00:11:57.027 --> 00:11:57.567
As I've said,

197
00:11:57.728 --> 00:12:01.030
all 12 patients reported improvement,

198
00:12:01.491 --> 00:12:02.912
some huge improvement,

199
00:12:03.152 --> 00:12:05.154
some would be like moderate improvements,

200
00:12:05.354 --> 00:12:06.154
but in the end,

201
00:12:06.275 --> 00:12:08.656
it's all with very good improvements.

202
00:12:09.517 --> 00:12:14.101
There was no deterioration of the sexual function and no major morbidity.

203
00:12:14.721 --> 00:12:16.243
Only in the first few weeks,

204
00:12:16.303 --> 00:12:17.944
a couple of patients have hematuria,

205
00:12:18.445 --> 00:12:18.785
but then...

206
00:12:19.125 --> 00:12:19.605
Afterwards,

207
00:12:20.326 --> 00:12:21.747
most patients do very well.

208
00:12:22.207 --> 00:12:25.469
This actually prompts us to do subsequent trials.

209
00:12:26.490 --> 00:12:27.871
It is very interesting.

210
00:12:28.211 --> 00:12:29.052
Before to finish,

211
00:12:29.352 --> 00:12:31.634
what are you working on right now?

212
00:12:31.834 --> 00:12:33.735
And what are your plans for the future?

213
00:12:34.015 --> 00:12:34.395
As I said,

214
00:12:34.776 --> 00:12:39.579
we are now waiting for the results from the European trial,

215
00:12:39.879 --> 00:12:43.402
which is the first trial in Europe on TMA for BPH.

216
00:12:43.642 --> 00:12:48.245
And I'm now gathering more centers to participate in.

217
00:12:48.745 --> 00:12:50.086
next phase of the trial,

218
00:12:50.306 --> 00:12:51.026
which is coming up,

219
00:12:51.186 --> 00:12:54.828
and we're going to do a comparative trial with other treatment options.

220
00:12:55.128 --> 00:12:56.009
So yeah,

221
00:12:56.049 --> 00:12:56.629
this is the plan.

222
00:12:57.149 --> 00:12:59.431
We will follow that with very intentions.

223
00:12:59.751 --> 00:13:00.491
So thank you,

224
00:13:00.691 --> 00:13:00.951
Dr.

225
00:13:01.031 --> 00:13:01.151
Chu,

226
00:13:01.291 --> 00:13:03.072
for this stunning discussion.

227
00:13:03.593 --> 00:13:08.115
I would like to say thank you because it was a pleasure to have you for this second podcast,

228
00:13:08.375 --> 00:13:10.556
and I hope to see you soon in Prostato.

229
00:13:10.896 --> 00:13:12.077
Thank you and have a good day.

